PHILADELPHIA, April 26, 2017 /PRNewswire/ -- Aberdeen
Israel Fund, Inc. (the "Fund") (NYSE MKT: ISL), a closed-end
equity fund, announced today its performance data and portfolio
composition as of March 31, 2017.
The Fund's total returns for various periods through
March 31, 2017 are provided
below. (All figures are based on distributions reinvested at
the dividend reinvestment price and are stated
net-of-fees):
|
Cumulative as of
03/31/17
|
Annualized as of
03/31/17
|
|
1 Month
|
3 Month
|
YTD
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
Since
Inception
|
NAV
|
0.3
|
6.5
|
6.5
|
3.8
|
2.1
|
7.9
|
6.2
|
7.3
|
Market
Price
|
3.1
|
9.1
|
9.1
|
7.8
|
1.5
|
7.4
|
5.8
|
6.5
|
TA-125
|
-0.8
|
3.5
|
3.5
|
3.7
|
-2.1
|
4.4
|
3.7
|
n/a1
|
On March 31, 2017, the Fund's net
assets amounted to US$80.5 million
and the Fund's NAV per share was US$20.39.
1 There is no since inception figure for the
TA-125 Index because the inception date of the index is
January 1, 1999.
As of March 31, 2017, the
portfolio was invested as follows:
Portfolio
Composition
|
Percent of
Net Assets
|
Information
Technology
|
30.0
|
Financials
|
15.6
|
Health
Care
|
15.1
|
Materials
|
11.0
|
Consumer
Staples
|
7.9
|
Real
Estate
|
5.2
|
Industrials
|
4.9
|
Telecommunications
|
4.8
|
Consumer
Discretionary
|
2.9
|
Cash
|
2.7
|
The Fund's ten largest equity holdings as of March 31, 2017, representing 67.6% of net assets,
were:
Stock
|
Percent
of
Net
Assets
|
Check Point Software
Technologies
|
12.6
|
Frutarom
Industries
|
8.7
|
Ituran Location and
Control
|
8.2
|
Teva Pharmaceutical
Industries
|
7.1
|
Perrigo
|
6.6
|
Azrieli
Group
|
5.4
|
Amdocs
Ltd.
|
4.8
|
Bezeq Israeli
Telecommunication
|
4.7
|
Mizrahi Tefahot
Bank
|
4.7
|
Rami Levy
|
4.7
|
Important Information
Aberdeen Asset Management Inc.
has prepared this report based on information sources believed to
be accurate and reliable. However, the figures are unaudited
and neither the Fund, Aberdeen Asset Managers Limited (the
Investment Adviser), nor any other person guarantees their
accuracy. Investors should seek their own professional advice
and should consider the investment objectives, risks, charges and
expenses before acting on this information. The Investment Adviser
and Aberdeen Asset Management Inc. are each a wholly owned
subsidiary of Aberdeen Asset Management PLC. Aberdeen Asset
Management PLC announced on March 6,
2017 that it entered into an agreement with Standard Life
plc to carry out an all-share merger, subject to regulatory and
other approvals. More information about the potential merger
can be found on Aberdeen's website at www.aberdeen-asset.com.
Aberdeen is a U.S. registered service mark of Aberdeen Asset
Management PLC.
Closed-end funds are traded on the secondary market through one
of the stock exchanges. The Fund's investment return and principal
value will fluctuate so that an investor's shares may be worth more
or less than the original cost. Shares of closed-end funds may
trade above (a premium) or below (a discount) the net asset value
(NAV) of the fund's portfolio. There is no assurance that the Fund
will achieve its investment objective.
Total return figures with distributions reinvested at the
dividend reinvestment price are stated net-of-fees and represents
past performance. Past performance is not indicative of
future results, current performance may be higher or lower.
Holdings are subject to change and are provided for informational
purposes only and should not be deemed as a recommendation to buy
or sell the securities shown. Inception date October 29, 1992.
If you wish to receive this information electronically, please
contact: InvestorRelations@aberdeen-asset.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/aberdeen-israel-fund-inc-announces-performance-data-and-portfolio-composition-300446604.html
SOURCE Aberdeen Israel Fund, Inc.